Пряности и специи
‹‹1››. Srinivasan K. Antioxidant potential of spices and their active constituents. Crit Rev Food Sci Nutr. 2014;54(3):352–72.
‹‹2››. Carlsen MH, Halvorsen BL, Holte K, et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010;9:3.
‹‹3››. Tapsell LC, Hemphill I, Cobiac L, et al. Health benefits of herbs and spices: the past, the present, the future. Med J Aust. 2006;185(4 Suppl):S4–24.
‹‹4››. Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann NY Acad Sci. 2005;1056:206–17.
‹‹5››. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013;15(1):195–218.
‹‹6››. Agarwal KA, Tripathi CD, Agarwal BB, Saluja S. Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebocontrolled study. Surg Endosc. 2011;25(12):3805–10.
‹‹7››. Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res. 2012;26(11):1719–25.
‹‹8››. Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin Interv Aging. 2014;9:451–8.
‹‹9››. Khajehdehi P, Zanjaninejad B, Afl aki E, et al. Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study. J Ren Nutr. 2012;22(1):50–7.
‹‹10››. Vecchi Brumatti L, Marcuzzi A, Tricarico PM, Zanin V, Girardelli M, Bianco AM. Curcumin and inflammatory bowel disease: potential and limits of innovative treatments. Molecules. 2014;19(12):21127–53.
‹‹11››. Lang A, Salomon N, Wu JC, et al. Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial. Clin Gastroenterol Hepatol. 2015;13(8):1444–49.e1.
‹‹12››. Percival SS, Vanden Heuvel JP, Nieves CJ, Montero C, Migliaccio AJ, Meadors J. Bioavailability of herbs and spices in humans as determined by ex vivo inflammatory suppression and DNA strand breaks. J Am Coll Nutr. 2012;31(4):288–94.
‹‹13››. Gupta SC, Sung B, Kim JH, Prasad S, Li S, Aggarwal BB. Multitargeting by turmeric, the golden spice: from kitchen to clinic. Mol Nutr Food Res. 2013;57(9):1510–28.
‹‹14››. Siruguri V, Bhat RV. Assessing intake of spices by pattern of spice use, frequency of consumption and portion size of spices consumed from routinely prepared dishes in southern India. Nutr J. 2015;14:7.
‹‹15››. Gilani AH, Rahman AU. Trends in ethnopharmacology. J Ethnopharmacol. 2005;100 (1–2):43–9.
‹‹16››. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007;70(3):461–77.
‹‹17››. Atal CK, Dubey RK, Singh J. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Ther. 1985; 232(1):258–62.
‹‹18››. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64(4): 353–6.
‹‹19››. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807–18.
‹‹20››. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807–18.
‹‹21››. Jacobson MS. Cholesterol oxides in Indian ghee: possible cause of unexplained high risk of atherosclerosis in Indian immigrant populations. Lancet. 1987;2(8560):656–8.
‹‹22››. Percival SS, Vanden Heuvel JP, Nieves CJ, Montero C, Migliaccio AJ, Meadors J. Bioavailability of herbs and spices in humans as determined by ex vivo inflammatory suppression and DNA strand breaks. J Am Coll Nutr. 2012;31(4):288–94.
‹‹23››. Arjmandi BH, Khalil DA, Lucas EA, et al. Soy protein may alleviate osteoarthritis symptoms. Phytomedicine. 2004;11(7–8):567–75.
‹‹24››. Agarwal KA, Tripathi CD, Agarwal BB, Saluja S. Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebocontrolled study. Surg Endosc. 2011;25(12):3805–10.
‹‹25››. Aggarwal BB, Yuan W, Li S, Gupta SC. Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: identifi cation of novel components of turmeric. Mol Nutr Food Res. 2013;57(9):1529–42.
‹‹26››. Kim JH, Gupta SC, Park B, Yadav VR, Aggarwal BB. Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-?B and NF-?B-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. Mol Nutr Food Res. 2012;56(3):454–65.
‹‹27››. Aggarwal BB, Yuan W, Li S, Gupta SC. Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: identification of novel components of turmeric. Mol Nutr Food Res. 2013;57(9):1529–42.
‹‹28››. Bengmark S, Mesa MD, Gil A. Plant-derived health: the Effects of turmeric and curcuminoids. Nutr Hosp. 2009;24(3):273–81.
‹‹29››. Cao J, Jia L, Zhou HM, Liu Y, Zhong LF. Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. Toxicol Sci. 2006;91(2):476–83.
‹‹30››. Turmeric and curcumin supplements and spices. https://www.consumerlab.com/reviews/turmeric-curcumin-supplements-spice-review/turmeric/ March 3, 2015. Accessed April 17, 2015.
‹‹31››. Rasyid A, Lelo A. The effect of curcumin and placebo on human gall-bladder function: an ultrasound study. Aliment Pharmacol Ther. 1999;13(2):245–9.
‹‹32››. Rasyid A, Rahman AR, Jaalam K, Lelo A. Effect of different curcumin dosages on human gall bladder. Asia Pac J Clin Nutr. 2002;11(4):314–8.
‹‹33››. Asher GN, Spelman K. Clinical utility of curcumin extract. Altern Ther Health Med. 2013; 19(2):20–2.
‹‹34››. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as «curecumin»: from kitchen to clinic. Biochem Pharmacol. 2008;75(4):787–809.
‹‹35››. Ghosh Das S, Savage GP. Total and soluble oxalate content of some Indian spices. Plant Foods Hum Nutr. 2012;67(2):186–90.
‹‹36››. Asher GN, Spelman K. Clinical utility of curcumin extract. Altern Ther Health Med. 2013; 19(2):20–2.
‹‹37››. Poole C, Bushey B, Foster C, et al. The effects of a commercially available botanical supplement on strength, body composition, power output, and hormonal profiles in resistance-trained males. J Int Soc Sports Nutr. 2010;7:34.
‹‹38››. Shabbeer S, Sobolewski M, Anchoori RK, et al. Fenugreek: a naturally occurring edible spice as an anticancer agent. Cancer Biol Ther. 2009;8(3):272–8.
‹‹39››. Mebazaa R, Rega B, Camel V. Analysis of human male armpit sweat after fenugreek ingestion: characterisation of odour active compounds by gas chromatography coupled to mass spectrometry and olfactometry. Food Chem. 2011;128(1):227–35.
‹‹40››. Korman SH, Cohen E, Preminger A. Pseudo-maple syrup urine disease due to maternal prenatal ingestion of fenugreek. J Paediatr Child Health. 2001;37(4):403–4.
‹‹41››. Marsh TL, Arriola PE. The science of salsa: antimicrobial properties of salsa components to learn scientific methodology. J Microbiol Biol Educ. 2009;10(1):3–8.
‹‹42››. Mauer L, El-Sohemy A. Prevalence of cilantro (Coriandrum sativum) disliking among different ethnocultural groups. Flavour. 2012;1:8.
‹‹43››. Eriksson N, Wu S, Do CB, et al. A genetic variant near olfactory receptor genes influences cilantro preference. Flavour. 2012;1:22.
‹‹44››. Knaapila A, Hwang LD, Lysenko A, et al. Genetic analysis of chemosensory traits in human twins. Chem Senses. 2012;37(9):869–81.
‹‹45››. Eriksson N, Wu S, Do CB, et al. A genetic variant near olfactory receptor genes influences cilantro preference. Flavour. 2012;1:22.
‹‹46››. Sahib NG, Anwar F, Gilani AH, Hamid AA, Saari N, Alkharfy KM. Coriander (Coriandrum sativum L.): a potential source of high-value components for functional foods and nutraceuticals— a review. Phytother Res. 2013;27(10):1439–56.
‹‹47››. Rajeshwari CU, Siri S, Andallu B. Antioxidant and antiarthritic potential of coriander (Coriandrum sativum L.) leaves. e-SPEN J. 2012;7(6):e223–8.
‹‹48››. Geppetti P, Fusco BM, Marabini S, Maggi CA, Fanciullacci M, Sicuteri F. Secretion, pain and sneezing induced by the application of capsaicin to the nasal mucosa in man. Br J Pharmacol. 1988;93(3):509–14.
‹‹49››. Nesbitt AD, Goadsby PJ. Cluster headache. BMJ. 2012;344:e2407.
‹‹50››. Fusco BM, Marabini S, Maggi CA, Fiore G, Geppetti P. Preventative effect of repeated nasal applications of capsaicin in cluster headache. Pain. 1994;59(3):321–5.
‹‹51››. Nozu T, Kudaira M. Altered rectal sensory response induced by balloon distention in patients with functional abdominal pain syndrome. Biopsychosoc Med. 2009;3:13.
‹‹52››. Bortolotti M, Porta S. Effect of red pepper on symptoms of irritable bowel syndrome: preliminary study. Dig Dis Sci. 2011;56(11):3288–95.
‹‹53››. Bortolotti M, Coccia G, Grossi G. Red pepper and functional dyspepsia. N Engl J Med. 2002;346(12):947–8.
‹‹54››. Hennessy S, Leonard CE, Newcomb C, Kimmel SE, Bilker WB. Cisapride and ventricular arrhythmia. Br J Clin Pharmacol. 2008;66(3):375–85.
‹‹55››. Mustafa T, Srivastava KC. Ginger (Zingiber officinale) in migraine headache. J Ethnopharmacol. 1990;29(3):267–73.
‹‹56››. Gottlieb MS. Discovering AIDS. Epidemiology. 1998;9(4):365–7.
‹‹57››. Ghofrani HA, Osterloh IH, Grimminger F. Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov. 2006;5(8):689–702.
‹‹58››. Vandenbroucke JP. In defense of case reports and case series. Ann Intern Med. 2001;134(4): 330–4.
‹‹59››. Maghbooli M, Golipour F, Moghimi Esfandabadi A, Yousefi M. Comparison between the efficacy of ginger and sumatriptan in the ablative treatment of the common migraine. Phytother Res. 2014;28(3):412–5.
‹‹60››. Desai HG, Kalro RH, Choksi AP. Effect of ginger & garlic on DNA content of gastric aspirate. Indian J Med Res. 1990;92:139–41.
‹‹61››. Wasson S, Jayam VK. Coronary vasospasm and myocardial infarction induced by oral sumatriptan. Clin Neuropharmacol. 2004;27(4):198–200.
‹‹62››. Laine K, Raasakka T, Mantynen J, Saukko P. Fatal cardiac arrhythmia after oral sumatriptan. Headache. 1999;39(7):511–2.
‹‹63››. Maghbooli M, Golipour F, Moghimi Esfandabadi A, Yousefi M. Comparison between the efficacy of ginger and sumatriptan in the ablative treatment of the common migraine. Phytother Res. 2014;28(3):412–5.
‹‹64››. Coco AS. Primary dysmenorrhea. Am Fam Physician. 1999;60(2):489–96.
‹‹65››. Kashefi F, Khajehei M, Tabatabaeichehr M, Alavinia M, Asili J. Comparison of the effect of ginger and zinc sulfate on primary dysmenorrhea: a placebo-controlled randomized trial. Pain Manag Nurs. 2014;15(4):826–33.
‹‹66››. Rahnama P, Montazeri A, Huseini HF, Kianbakht S, Naseri M. Effect of Zingiber officinale R. rhizomes (ginger) on pain relief in primary dysmenorrhea: a placebo randomized trial. BMC Complement Altern Med. 2012;12:92.
‹‹67››. Ozgoli G, Goli M, Moattar F. Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea. J Altern Complement Med. 2009;15(2): 129–32.
‹‹68››. Kashefi F, Khajehei M, Alavinia M, Golmakani E, Asili J. Effect of ginger (Zingiber officinale) on heavy menstrual bleeding: a placebo-controlled, randomized clinical trial. Phytother Res. 2015;29(1):114–9.
‹‹69››. Khayat S, Kheirkhah M, Behboodi Moghadam Z, Fanaei H, Kasaeian A, Javadimehr M. Effect of treatment with ginger on the severity of premenstrual syndrome symptoms. ISRN Obstet Gynecol. 2014;2014:792708.
‹‹70››. Mowrey DB, Clayson DE. Motion sickness, ginger, and psychophysics. Lancet. 1982;1(8273): 655–7.
‹‹71››. Palatty PL, Haniadka R, Valder B, Arora R, Baliga MS. Ginger in the prevention of nausea and vomiting: a review. Crit Rev Food Sci Nutr. 2013;53(7):659–69.
‹‹72››. Ding M, Leach M, Bradley H. The effectiveness and safety of ginger for pregnancy-induced nausea and vomiting: a systematic review. Women Birth. 2013;26(1):e26–30.
‹‹73››. Carlsen MH, Halvorsen BL, Holte K, et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010;9:3.
‹‹74››. American Thyroid Association Taskforce on Radioiodine Safety, Sisson JC, Freitas J, et al. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association. Thyroid. 2011;21(4):335–46.
‹‹75››. Metso S, Auvinen A, Huhtala H, Salmi J, Oksala H, Jaatinen P. Increased cancer incidence after radioiodine treatment for hyperthyroidism. Cancer. 2007;109(10):1972–9.
‹‹76››. Arami S, Ahmadi A, Haeri SA. The radioprotective effects of Origanum vulgare extract against genotoxicity induced by (131)I in human blood lymphocyte. Cancer Biother Radiopharm. 2013;28(3):201–6.
‹‹77››. Berrington D, Lall N. Anticancer activity of certain herbs and spices on the cervical epithelial carcinoma (HeLa) cell line. Evid Based Complement Alternat Med. 2012;2012:564927.
‹‹78››. Gunawardena D, Shanmugam K, Low M, et al. Determination of anti-inflammatory activities of standardised preparations of plant-and mushroom-based foods. Eur J Nutr. 2014;53(1): 335–43.
‹‹79››. Al Dhaheri Y, Attoub S, Arafat K, et al. Anti-metastatic and anti-tumor growth effects of Origanum majorana on highly metastatic human breast cancer cells: inhibition of NF?B signaling and reduction of nitric oxide production. PLoS ONE. 2013;8(7):e68808.
‹‹80››. Haj-Husein I, Tukan S, Alkazaleh F. The effect of marjoram (Origanum majorana) tea on the hormonal profile of women with polycystic ovary syndrome: a randomised controlled pilot study. J Hum Nutr Diet. 2015; doi: 10.1111/jhn.12290.
‹‹81››. Carlsen MH, Halvorsen BL, Holte K, et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010;9:3.
‹‹82››. Carlsen MH, Halvorsen BL, Holte K, et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010;9:3.
‹‹83››. Baliga MS, Dsouza JJ. Amla (Emblica officinalis Gaertn), a wonder berry in the treatment and prevention of cancer. Eur J Cancer Prev. 2011;20(3):225–39.
‹‹84››. Carlsen MH, Halvorsen BL, Holte K, et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010;9:3.
‹‹85››. Darvin ME, Patzelt A, Knorr F, Blume-Peytavi U, Sterry W, Lademann J. One-year study on the variation of carotenoid antioxidant substances in living human skin: influence of dietary supplementation and stress factors. J Biomed Opt. 2008;13(4):044028.
‹‹86››. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab. 2000; 85(8): 2970–3.
‹‹87››. Ghanim H, Mohanty P, Pathak R, Chaudhuri A, Sia CL, Dandona P. Orange juice or fructose intake does not induce oxidative and inflammatory response. Diabetes Care. 2007;30(6): 1406–11.
‹‹88››. Prior RL, Gu L, Wu X, et al. Plasma antioxidant capacity changes following a meal as a measure of the ability of a food to alter in vivo antioxidant status. J Am Coll Nutr. 2007;26(2):170–81.
‹‹89››. Carlsen MH, Halvorsen BL, Holte K, et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010;9:3.
‹‹90››. Saper RB, Kales SN, Paquin J, et al. Heavy metal content of Ayurvedic herbal medicine products. JAMA. 2004;292(23):2868–73.
‹‹91››. Martena MJ, van der Wielen JC, Rietjens IM, Klerx WN, de Groot HN, Konings EJ. Monitoring of mercury, arsenic, and lead in traditional Asian herbal preparations on the Dutch market and estimation of associated risks. Food Addit Contam Part A. 2010;27(2):190–205.
‹‹92››. Skulas-Ray AC, Kris-Etherton PM, Teeter DL, Chen CYO, Vanden Heuvel JP, West SG. A high antioxidant spice blend attenuates postprandial insulin and triglyceride responses and increases some plasma mea sures of antioxidant activity in healthy, overweight men. J Nutr. 2011;141(8): 1451–7.
‹‹93››. Tomita LY, Roteli-Martins CM, Villa LL, Franco EL, Cardoso MA, BRINCA Study Team. Associations of dietary dark-green and deep-yellow vegetables and fruits with cervical intraepithelial neoplasia: modification by smoking. Br J Nutr. 2011;105(6):928–37.
‹‹94››. Gomaa EA, Gray JI, Rabie S, Lopez-Bote C, Booren AM. Polycyclic aromatic hydrocarbons in smoked food products and commercial liquid smoke flavourings. Food Addit Contam. 1993; 10(5): 503–21.
‹‹95››. Fritschi G, Prescott WR Jr. Morphine levels in urine subsequent to poppy seed consumption. Forensic Sci Int. 1985;27(2):111–7.
‹‹96››. Hahn A, Michalak H, Begemann K, et al. Severe health impairment of a 6-week-old infant related to the ingestion of boiled poppy seeds. Clin Toxicol. 2008;46:607.
‹‹97››. Sproll C, Perz RC, Lachenmeier DW. Optimized LC/MS/MS analysis of morphine and codeine in poppy seed and evaluation of their fate during food processing as a basis for risk analysis. J Agric Food Chem. 2006;54(15):5292–8.
‹‹98››. European Food Safety Authority. Scientific opinion on the risks for public health related to the presence of opium alkaloids in poppy seeds. EFSA J. 2011;9(11):2405.
‹‹99››. Lachenmeier DW, Sproll C, Musshoff F. Poppy seed foods and opiate drug testing — where are we today? Ther Drug Monit. 2010;32(1):11–8.
‹‹100››. Sproll C, Perz RC, Lachenmeier DW. Optimized LC/MS/MS analysis of morphine and codeine in poppy seed and evaluation of their fate during food processing as a basis for risk analysis. J Agric Food Chem. 2006;54(15):5292–8.
‹‹101››. Lachenmeier DW, Sproll C, Musshoff F. Poppy seed foods and opiate drug testing — where are we today? Ther Drug Monit. 2010;32(1):11–8.
‹‹102››. Idle JR. Christmas gingerbread (Lebkuchen) and Christmas cheer — review of the potential role of mood elevating amphetamine-like compounds formed in vivo and in furno. Prague Med Rep. 2005;106(1):27–38.
‹‹103››. Payne RB. Nutmeg intoxication. N Engl J Med. 1963;269:36–8.
‹‹104››. Cushny AR. Nutmeg poisoning. Proc R Soc Med. 1908;1(Ther Pharmacol Sect):39–44.
‹‹105››. Williams EY, West F. The use of nutmeg as a psychotropic drug. Report of two cases. J Natl Med Assoc. 1968;60(4):289–90.
‹‹106››. Williams EY, West F. The use of nutmeg as a psychotropic drug. Report of two cases. J Natl Med Assoc. 1968;60(4):289–90.
‹‹107››. Scholefield JH. Nutmeg — an unusual overdose. Arch Emerg Med. 1986;3(2):154–5.
‹‹108››. Davis PA, Yokoyama W. Cinnamon intake lowers fasting blood glucose: meta-analysis. J Med Food. 2011;14(9):884–9.
‹‹109››. Solomon TPJ, Blannin AK. Effects of short-term cinnamon ingestion on in vivo glucose tolerance. Diabetes Obes Metab. 2007;9(6):895–901.
‹‹110››. Solomon TPJ, Blannin AK. Changes in glucose tolerance and insulin sensitivity following 2 weeks of daily cinnamon ingestion in healthy humans. Eur J Appl Physiol. 2009;105(6): 969–76.
‹‹111››. Fotland T?, Paulsen JE, Sanner T, Alexander J, Hus?y T. Risk assessment of coumarin using the bench mark dose (BMD) approach: children in Norway which regularly eat oatmeal porridge with cinnamon may exceed the TDI for coumarin with several folds. Food Chem Toxicol. 2012;50(3–4):903–12.
‹‹112››. Wickenberg J, Lindstedt S, Berntorp K, Nilsson J, Hlebowicz J. Ceylon cinnamon does not affect postprandial plasma glucose or insulin in subjects with impaired glucose tolerance. Br J Nutr. 2012;107(12):1845–9.
‹‹113››. Davis PA, Yokoyama W. Cinnamon intake lowers fasting blood glucose: meta-analysis. J Med Food. 2011;14(9):884–9.